Radiation Oncology

Radiation therapy uses high-energy radiation to damage cancer cells' DNA and destroy their ability to divide and grow. It is delivered using linear accelerators, proton accelerators, metered cobalt-60 exposure, or brachytherapy where radioactive seeds are placed inside the patient on a temporary or permanent basis to kill cancer or relieve pain. The main radiation oncology society and annual conference is the American Society of Radiation Oncology (ASTRO).

Imaging may be misleading when determining the success of cancer treatment
A new analysis calls into question the use of imaging alone to determine the efficacy of ablative radiation therapy.
Prostate cancer radiotherapy timeline can be safely shortened
Isodose moderately hypofractionated radiotherapy allows patients to undergo just 4-5 weeks of treatment, compared to conventional therapy that can take around 8.
Simple CT metric predicts treatment-induced kidney impairment in prostate cancer patients
Though effective, Lu-177 radioligland therapy is not without side effects, some of which can be severe.
Tiny 'water bears' may hold key to reducing radiation-induced side effects
These animals are virtually indestructible and have long outlived the dinosaurs due to their ability to withstand extreme cold, heat, natural disasters and even cosmic radiation.
Orano Med breaks ground on $265M thorium production site
The new 7,000-square-meter plant is located in France and will begin production of thorium-228, necessary for the development of isotopes used in cancer treatments.

ASTRO 2018: SBRT an effective option for low-, intermediate-risk prostate cancer patients

Stereotactic body radiation therapy (SBRT) is a safe and effective treatment for patients with low- and intermediate-risk prostate cancer, according to research presented Oct. 22 at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.

ASTRO 2018: High-dose radiation therapy safe for kidney cancer patients with a single kidney

Using high-dose, high-precision radiation therapy to treat renal cell carcinoma (RCR) is safe for patients with one kidney, according to findings presented Oct. 22 at the American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas.

ASTRO 2018: African-Americans with prostate cancer respond better to radiation therapy than Caucasian men

Contrary to recent data suggesting African-Americans face a higher mortality risk from prostate cancer than Caucasian men, a new study presented at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting suggests African-American men may have higher cure rates when treated with radiation therapy than Caucasian men.

ASTRO 2018: Radiation therapy outcomes better for black prostate cancer patients than white patients

Black men with prostate cancer may have “comparatively higher” cure rates than white men when treated with radiation therapy, according to study results presented Oct. 22 at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.

ASTRO 2018: Side effects similar for women receiving weekly breast radiation therapy, daily treatments

Among women receiving radiation therapy to treat early-stage breast cancer, receiving larger individual doses was not associated with a significant increase in long-term side effects, according to a 10-year study presented Oct. 21 at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.

At ASTRO, Siemens Healthineers unveil RT Pro Edition for Biograph Vision for PET/CT radiation therapy planning

RT package of latest PET/CT scanner offers comprehensive therapy planning solution.

Fujifilm announces entry Into U.S. computed tomography market with unveiling of FCT Embrace at ASTRO 2018

World's first 85cm 64 and 128 slice wide bore CT unit for oncology

ASTRO 2018: Radiation therapy makes low recurrence rates among some breast cancer patients even lower

Radiation therapy can lower the chance of cancer recurrence in patients with low-risk breast cancer following breast conservation surgery, according to data presented Oct. 21 at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.

Radiation Oncology

Imaging may be misleading when determining the success of cancer treatment

Prostate cancer radiotherapy timeline can be safely shortened

Simple CT metric predicts treatment-induced kidney impairment in prostate cancer patients

Tiny 'water bears' may hold key to reducing radiation-induced side effects

Orano Med breaks ground on $265M thorium production site